• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Host Microbe . Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B viruses

tetano

Editor, Senior Moderator
Cell Host Microbe


. 2026 Mar 20:S1931-3128(26)00086-7.
doi: 10.1016/j.chom.2026.02.018. Online ahead of print.
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B viruses

Xiaoyu Cai[SUP] 1 [/SUP], Miao Fan[SUP] 2 [/SUP], Yanmei Zhai[SUP] 1 [/SUP], Wanyu Luo[SUP] 1 [/SUP], Shuning Liu[SUP] 1 [/SUP], Kexin Lv[SUP] 1 [/SUP], Min Zhao[SUP] 2 [/SUP], Lin Liu[SUP] 1 [/SUP], Siwei Zhou[SUP] 1 [/SUP], Mengxin Xu[SUP] 1 [/SUP], Bing He[SUP] 1 [/SUP], Yuzhu Sun[SUP] 1 [/SUP], Ruixin Zhao[SUP] 1 [/SUP], Xingchen Zhu[SUP] 1 [/SUP], Yu Kuang[SUP] 1 [/SUP], Hongjie Lu[SUP] 1 [/SUP], Xinyu Yue[SUP] 1 [/SUP], Kuibiao Li[SUP] 3 [/SUP], Yu Zhang[SUP] 4 [/SUP], Li Yuan[SUP] 4 [/SUP], Na Zhou[SUP] 4 [/SUP], Feng Ye[SUP] 4 [/SUP], Huan Liang[SUP] 5 [/SUP], Yiyun Chen[SUP] 3 [/SUP], Min Zheng[SUP] 6 [/SUP], Zhangyong Hong[SUP] 7 [/SUP], Dayan Wang[SUP] 8 [/SUP], Zeli Zhang[SUP] 9 [/SUP], Yue-Long Shu[SUP] 10 [/SUP], Jiwan Ge[SUP] 11 [/SUP], Yao-Qing Chen[SUP] 12 [/SUP]


Affiliations
Abstract

Antigenic drift in hemagglutinin (HA) enables influenza viruses to escape host immunity. Elucidating molecular features of antigenic drift is essential for updating seasonal vaccines and pandemic preparedness. Here, we found that influenza B viruses (IBVs) isolated after 2019 escaped neutralization by several previously identified broadly neutralizing monoclonal antibodies (bnAbs). Meanwhile, we identified two IBV bnAbs, CAV-CF22 and CAV-CH76, isolated via quadrivalent vaccine. They exhibited broad neutralizing activity against Victoria- and Yamagata-lineage viruses in vitro and protected in vivo against contemporary Victoria and Yamagata strains. Phylogenetic and structural analysis revealed fixation of K136E in post-2019 Victoria HA, disrupting epitopes targeted by most previously characterized head-directed IBV-monoclonal antibodies (mAbs). High-resolution structures reveal that, rather than engaging K136, CAV-CF22 and CAV-CH76 insert HCDR3 into the receptor-binding site (RBS) to sterically mimic sialic acid. The conservation of epitope residues underlies the antibodies' broad neutralizing activity against IBV and informs antibody- and vaccine-design strategies that are resilient to recent IBV drift.

Keywords: antigenic drift; broad neutralization; hemagglutinin; influenza B virus; monoclonal antibody; seasonal vaccine.

 
Back
Top Bottom